Sponsored webinar that reviewed the recommended tools for asthma assessment and management, pharmacotherapy considerations to improve management and control and the GINA guidance for COVID-19 and asthma.
Sponsored webinar that highlighted a new frontier of cannabis-related advocacy—state mandated health insurance coverage for non-FDA-approved cannabis products.
Migraine is a chronic neurologic disease characterized by attacks of throbbing, often unilateral pain exacerbated by physical activity. Cluster headache is less common. AMCP is pleased to offer these resources to you from our Market Insights Summit on Migraine and Cluster Headaches.
Psoriasis is a chronic autoimmune skin disease that speeds up the growth cycle of skin cells. AMCP is pleased to offer these resources to you from our Market Insights Summit on Psoriasis.
On November 2, AMCP submitted comments on CMS’s Third Interim Final Rule responding to the COVID-19 emergency, thanking the agency for granting pharmacists the authority to order COVID-19 diagnostic tests for Medicare beneficiaries and expressing concern about the agency’s new guidance which would limit COVID-19 diagnostic tests without an order.